Clivus chordomas: a systematic review and meta-analysis of contemporary surgical management.

医学 斜坡 脊索瘤 外科 入射(几何) 人口 颅骨 环境卫生 光学 物理
作者
Moujahed Labidi,Kentaro Watanabe,S. Bouazza,Damien Bresson,Anne Laure Bernat,Bernard George,Sébastien Froelich
出处
期刊:PubMed 卷期号:60 (4): 476-84 被引量:59
链接
标识
摘要

Chordomas are rare bony lesions arising from notochordal remnants. Technical advances in endoscopic surgery have allowed the median endonasal corridor to be used for a larger number of chordoma cases. However, very few studies have critically examined the data in support of the anterior midline approach (AMA), as compared to lateral and posterolateral transcranial corridors.A systematic search of the literature was done in March 2016 using EMBASE and PubMed for articles published between January 2006 and March 2016 to identify surgical series of clivus chordomas. Only articles describing chordomas cases arising from the clivus of craniocervical junction were included in the analysis.Twenty-seven articles were included in this systematic review, amounting to a total of 1050 patients. The weighted mean rate of GTR was 39.9% (range 0-78.3%) in this patient population. The surgical approaches were described in 16 papers, with 6 series reporting on surgeries done exclusively through the midline corridor (116 patients). In the remaining 10 series (495 patients), the AMA was used in a mean of 56.8% of cases. In studies including patients operated solely through an AMA, a higher GTR rate was obtained (60.7% vs. 42.0%). Postoperative complications were also different between the two cohorts, with lower cranial nerves deficits and CNS infections but higher incidence of CSF leak in the AMA group than in mixed surgical series. In a weighted mean follow-up time of 52.1±21.9 months, recurrences were observed in 38.2% of the total population of patients. Among 423 patients, the weighted 5-year PFS was 49.9±12.1% and the 5-year OS was 73.9±11.2% (N.=391). A random effects model was performed, combining data from studies reporting recurrence rates in GTR and non-GTR (N.=610), with a total odds ratio of having a recurrence for patients who had GTR vs non-GTR of 0.289 (95CI 0.184-0.453).In this systematic review and meta-analysis of studies published in the last decade, an estimated 5-year PFS of 49.9% and 5-year OS of 73.9% were obtained. The weighted mean GTR rate in the included study was 39.9%, with a significantly reduced occurrence of recurrence in complete resections. Although anterior midline approaches may allow for higher GTR rates and fewer neurological morbidity than traditional transcranial routes, their impact of long-term survival and disease control remains largely unknown.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
suan完成签到,获得积分10
刚刚
qixiaoqi发布了新的文献求助10
2秒前
石子完成签到 ,获得积分10
2秒前
lzw123456完成签到,获得积分10
2秒前
量子星尘发布了新的文献求助10
3秒前
3秒前
kcmat完成签到,获得积分20
3秒前
Iridesent0v0完成签到,获得积分10
4秒前
威威完成签到,获得积分10
5秒前
酷波er应助lh采纳,获得10
6秒前
小郑发布了新的文献求助10
6秒前
clock完成签到 ,获得积分10
6秒前
66完成签到,获得积分10
7秒前
Orange应助jinkk采纳,获得10
7秒前
RuiLi完成签到,获得积分10
7秒前
煎饼狗子关注了科研通微信公众号
7秒前
xxxxxb完成签到,获得积分10
7秒前
英姑应助糖糖采纳,获得10
7秒前
淡淡小土豆完成签到 ,获得积分10
8秒前
伶俐的高烽完成签到 ,获得积分10
9秒前
candy6663339完成签到,获得积分10
9秒前
9秒前
gao完成签到 ,获得积分0
10秒前
打打应助科研通管家采纳,获得10
10秒前
完美世界应助科研通管家采纳,获得10
10秒前
科研通AI2S应助科研通管家采纳,获得30
10秒前
英姑应助科研通管家采纳,获得10
10秒前
Akim应助科研通管家采纳,获得20
10秒前
sota完成签到,获得积分10
10秒前
无花果应助科研通管家采纳,获得10
10秒前
10秒前
10秒前
Ava应助科研通管家采纳,获得10
10秒前
爆米花应助科研通管家采纳,获得10
11秒前
SciGPT应助科研通管家采纳,获得10
11秒前
11秒前
田様应助科研通管家采纳,获得10
11秒前
11秒前
11秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds第二卷 1200
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066